Laboratory tests including classical parameters (platelet count, PT, aPTT, INR, and fibrinogen) of coagulopathy seem to be enough for the followup of CCHF. Protein S, protein C, APCR, and D-dimer levels were not associated with mortality.

The aim of the study was to investigate the occurence and species distribution of methicillin resistant staphylococci (MRS) in the nasal cavity of dogs. Nasal swabs were collected from 162 dogs entering private veterinary clinics in Hatay. Methicillin resistance was detected onto mannitol salt agar containing 2 µg/ml oxacillin and confirmed by mecA Polymerase Chain Reaction (PCR). Bacterial identification was done using 16S rRNA sequencing. Staphylococcal cassette chromosome mec (SCCmec) typing of these isolates were determined by multiplex PCR. Antimicrobial susceptibility testing were performed disk diffusion method and antimicrobial resistance genes were determined by PCR. Methicillin-resistant coagulase negative staphylococci (MRCNS) harbouring mecA were isolated from 15.4% (25/162) of dogs. The species identified were S. epidermidis (n=12), S. lentus (n=6), S. hominis (n=4), S. warneri (n=1), S. arlettae (n=1) and S. haemolyticus (n=1). mecA-mediated methicillin resistance in S. arlettae was described for the first time. Methicillin resistant Staphylococcus aureus (MRSA) and methicillin resistant Staphylococcus pseudintermedius (MRSP) were not detected. SCCmec type I, II, III and IV were identified in 1, 10, 9 and 5 MRS isolates, respectively. The results indicate that continuous surveillance is necessary to determine the emergence of MRS including MRSA. Keywords: Dog, Methicillin resistance, Staphylococci Köpeklerde Metisilin Dirençli Stafilokokların Prevalansı ÖzetBu çalışmanın amacı, köpeklerin nazal mukozalarında metisilin dirençli stafilokokların (MRS) varlığınının ve tür dağılımının belirlenmesidir. Bu amaçla, Hatay'da özel veteriner kliniklerine getirilen 162 köpekten nazal svablar alındı. Metisilin direncinin belirlenmesinde 2 µg/ml oksasillin içeren mannitollü tuzlu agar kullanıldı. Bakteriyel identifikasyon 16S rRNA dizi analizi ile gerçekleştirildi. Stafilokokal kromozomal kaset tiplendirmesi (SCCmec) için multipleks polimeraz zincir reaksiyonu (mPZR) yapıldı. Antimikrobiyal duyarlılıkları disk diffuzyon yöntemi ile ve antimikrobiyal direnç genleri PZR ile incelendi. Köpeklerin %15.42'ünden (25/162) mecA geni taşıyan MRS izole edildi. Yirmibeş MRS izolatı S. epidermidis (n=12), S. lentus (n=6), S. hominis (n=4), S. warneri (n=1), S. arlettae (n=1) ve S. haemolyticus (n=1) olarak identifiye edildi. S. arlettae'da mecA geni ilk kez belirlendi. Metisilin dirençli S. aureus (MRSA) ve S. pseudintermedius (MRSP) izole edilmedi. SCCmec tip I, II, III ve IV sırasıyla 1, 10, 9 and 5 MRS izolatında belirlendi. Sonuçlar, MRSA dahil MRS suşlarının ortaya çıkışını belirlemek için sürekli surveyansın gerekli olduğunu işaret etmektedir.

In the present study, mulberry seed oil (MSO) samples obtained from seeds of different mulberry varieties as well as concentrated mulberry juice production waste (mulberry pomace) were investigated. Radical scavenging capacity, tocopherol and total phenolic content of MSO were determined. It was observed that MSO contain unique amounts of δ‐tocopherol varying between 1645–2587 mg kg−1 oil depending on the variety. The secondary tocopherol homologue was γ‐tocopherol within a concentration range of 299–854 mg kg−1 oil. MSO exhibited a very high antioxidant capacity varying in the range of 1013–1743 and 2574–4522 mg α‐tocopherol equivalents (α‐TE) per kg of oil for 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH) and freeze‐dried 2,2′‐azino‐bis (3‐ethylbenzothiazoline‐6‐sulfonic acid) (FD‐ABTS) radical cation assays, respectively. Both antioxidant capacity and total phenolic content were higher for mulberry pomace oil compared with the seed oils. Fatty acid composition of MSO was also determined, and linoleic acid was found to be the primary fatty acid (66–80 %).

The increased risk for thrombosis is known as hypercoagulability or thrombophilia. Here, we investigated risk factors for thrombophilia which were screened in young adult patients presenting with thrombotic events or with recurrent abortions with unknown etiology. A total of 115 patients aged between 16 and 50 years who were found to harbor thrombophilia were retrospectively evaluated. The laboratory investigations performed for the assessment of thrombophilia included protein C, protein S, antithrombin III deficiencies, activated protein C resistance, factor V Leiden (FVL), prothrombin 20210A (PT 20210) and methylenetetrahydrofolate reductase (MTHFR) gene mutations, factor VIII elevation, lupus anticoagulant and antiphospholipid antibodies (APA). In 66% of the cases a single thrombophilic defect was identified while some of the patients had combined thrombophilic defects. The most common thrombophilic defect was mutation in the MTHFR gene, and was followed by FVL mutation, the presence of APA and PT 20210 gene mutation, respectively. The patients were divided into two different age groups, 16-35 and 36-50 years, and arterial thrombosis was more common in the older age group. Our results indicated that some important thrombophilic defects such as gene mutations may appear in young adult patients presenting with thrombotic events.

Higher levels of CD3+CD8+ T lymphocytes were detected in fatal compared to non-fatal CCHF cases. Despite this cytotoxic immune activation, a fatal outcome could not be prevented. We hypothesize that high viral load and other factors may influence this outcome, although more studies are required to explain the pathogenesis of CCHF.